Novo Nordisk says Wegovy can help heart disease patients—and not just because it produces weight loss
Fierce Pharma
NOVEMBER 13, 2023
Novo Nordisk has made a splash with its GLP-1 drugs that have allowed patients to achieve significant weight loss. | Novo Nordisk has made a splash with its GLP-1 drugs that have allowed patients to achieve significant weight loss. Now the Danish company appears on the verge of another breakthrough, showing that the use of its obesity treatment Wegovy can reduce the risk of heart attack.
Let's personalize your content